Clinical Trials Browser

Immune Checkpoint Inhibitor-Induced Dermatitis × Therapeutics × 90 days × Clear all

NCT07530224 2026-04-15

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

Phase 2 Not yet recruiting

Immune Checkpoint Inhibitor-Induced Dermatitis